SIRT5 and nonpapillary renal cell carcinoma: The results of our study showed that SIRT5 functioned as a tumor suppressor in ccRCC and correlated with metabolic reprogramming during tumor growth and metastasis by regulating the hyposuccinylation of PHDA1.